134
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The Association of Oxidative Stress with Hypertensive Retinopathy

, , &
Pages 16-19 | Received 15 Mar 2012, Accepted 06 Apr 2012, Published online: 09 May 2012

REFERENCES

  • Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38:263–355.
  • Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N. Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb 2009; 16:355–362.
  • Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005; 112:2078–2080.
  • Lee DH, Jacobs DR Jr, Gross M, . Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358–1366.
  • Shankar A, Li J. Association between serum gamma-glutamyl transferase level and prehypertension among US adults. Circ J 2007; 71:1567–1572.
  • André P, Balkau B, Born C, Charles MA, Eschwège E; D.E.S.I.R Study Group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R cohort. Diabetologia 2006; 49:2599–2603.
  • Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004; 27:1427–1432.
  • Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 1997; 146:1019–1024.
  • Lee DS, Evans JC, Robins SJ, . Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007; 27:127–133.
  • Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS. Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes. Diabetes Res Clin Pract 2001; 52:113–118.
  • Wong TY, Mitchell P. The eye in hypertension. N Engl J Med 2007; 369:425–435.
  • Porta M, Grosso A, Veglio F. Hypertensive retinopathy: there’s more than meets the eye. J Hypertens 2005; 23:683–696.
  • Wong TY, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 2005; 73–74:57–70.
  • Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268:336–345.
  • Chobanian AV, Bakris GL, Black HR, ; National Heart Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289: 2560–2571.
  • Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486–2497.
  • Friedewald WT, Levi RI, Fredricksen DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.
  • Lee DH, Ha MH, Kim KY, Jin DG, Jacobs DR. Gamma-glutamyltransferase: an effect modifier in the association between age and hypertension in a 4-year follow-up study. J Hum Hypertens 2004; 18:803–807.
  • Yamada Y, Ikai E, Tsuritani I, Ishizaki M, Honda R, Ishida M. The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers. Hypertens Res 1995; 18:295–301.
  • Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 2005; 25:311–317.
  • Zeng C, Villar VA, Yu P, Zhou L, Jose PA. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens 2009; 2:156–178.
  • Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharm Des 2004; 10:1695–1698.
  • Giner V, Tormos C, Chavas FJ, Saez G, Redon J. Microalbuminuria and oxidative stress in essential hypertension. J Intern Med 2004; 255:588–594.
  • Minuz P, Patrignani P, Gaino S, . Determinants of platelet activation in human essential hypertension. Hypertension 2004; 43:64–70.
  • Purushothaman S, Nair RR, Harikrishnan VS, Fernandez AC. Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat. Mol Cell Biochem 2011; 351:59–64.
  • Yilmaz MI, Sonmez A, Kilic S, . The association of plasma adiponectin levels with hypertensive retinopathy. Eur J Endocrinol 2005; 152:233–240.
  • DellaCroce JT, Vitale AT. Hypertension and the eye. Curr Opin Ophthalmol 2008; 19:493–498.
  • Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 369:425–435.
  • Lowenthal MN, Zimlichman R. Resolution of hypertensive retinopathy despite persistent high diastolic pressure. South Med J 1993; 86:190–193.
  • Coban E, Alkan E, Altuntas S, Akar Y. Serum ferritin levels correlate with hypertensive retinopathy. Med Sci Monit 2010; 16:CR92–CR95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.